P A Bartlett
Overview
Explore the profile of P A Bartlett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
445
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodionov R, Bartlett P, He C, Vos S, Focke N, Ourselin S, et al.
Neuroimage Clin
. 2015 Apr;
7:788-91.
PMID: 25844331
Rationale: Qualitatively, FLAIR MR imaging is sensitive to the detection of hippocampal sclerosis (HS). Quantitative analysis of T2 maps provides a useful objective measure and increased sensitivity over visual inspection...
2.
Bartlett P, Symms M, Free S, Duncan J
AJNR Am J Neuroradiol
. 2007 Jun;
28(6):1095-8.
PMID: 17569966
Background And Purpose: T2 mapping is useful for identifying and quantifying abnormalities of the hippocampus and amygdala. It is particularly useful in the presurgical evaluation of patients with temporal lobe...
3.
Bartlett P, Richardson M, Duncan J
J Neurol Neurosurg Psychiatry
. 2002 Nov;
73(6):753-5.
PMID: 12438484
Objectives: To implement and validate the use of coronal dual echo T2 maps for the measurement of T2 relaxation time of the amygdala (AT2) as a rapid and reproducible method...
4.
Liu R, Lemieux L, Bell G, Bartlett P, Sander J, Sisodiya S, et al.
Neuroimage
. 2001 Aug;
14(1 Pt 1):231-43.
PMID: 11525333
Experimental and human data suggest that progressive cerebral damage may result from the cumulative effect of brief recurrent seizures. Longitudinal studies addressing this fundamental question, however, are lacking. We have...
5.
An M, Toochinda T, Bartlett P
J Org Chem
. 2001 Apr;
66(4):1326-33.
PMID: 11312963
Shikimate and other intermediates of the shikimate-chorismate pathway are densely functionalized structures that seem to offer limited options for skeletal modification. We designed and synthesized cyclopentylidenes 1 and 2, as...
6.
Woermann F, Steiner H, Barker G, Bartlett P, Elger C, Duncan J, et al.
J Magn Reson Imaging
. 2001 Mar;
13(4):547-52.
PMID: 11276098
To evaluate the use of cerebrospinal fluid (CSF) signal nulling in MR T2 measurements of the hippocampus in normal control subjects and patients with temporal lobe epilepsy (TLE), dual-echo acquisitions...
7.
Woermann F, McLean M, Bartlett P, Barker G, Duncan J
Brain
. 2001 Feb;
124(Pt 2):427-36.
PMID: 11157569
In patients with malformations of cortical development (MCD), widespread structural abnormalities of the brain have been demonstrated using volumetric MRI, and associated with poor post-surgical outcome in patients with localization-related...
8.
Fujinaga M, Cherney M, Tarasova N, Bartlett P, Hanson J, James M
Acta Crystallogr D Biol Crystallogr
. 2000 Mar;
56(Pt 3):272-9.
PMID: 10713513
The refined crystal structure of the complex between human pepsin and a synthetic phosphonate inhibitor, Iva-Val-Val-Leu(P)-(O)Phe-Ala-Ala-OMe [Iva = isovaleryl, Leu(P) = the phosphinic acid analog of L-leucine, (O)Phe = L-3-phenyllactic...
9.
Wieshmann U, Symm M, Bartlett P, Shorvon S, Clark C, Barker G
J Neurol Neurosurg Psychiatry
. 1999 May;
66(6):797-8.
PMID: 10329761
No abstract available.
10.
Woermann F, McLean M, Bartlett P, Parker G, Barker G, Duncan J
Ann Neurol
. 1999 Mar;
45(3):369-76.
PMID: 10072052
Single-voxel proton magnetic resonance spectroscopy (1H MRS) has shown abnormalities in patients with temporal lobe epilepsy (TLE) and hippocampal sclerosis (HS). Many TLE patients, however, do not have HS or...